One of the measures that most companies took to stem the spread of coronavirus disease 2019 (COVID-19) is allowing employees to work from home. However, employers are facing massive losses and challenges such as poor performance and loss of productivity. With the growing need to bring employees back to the office, startups and established companies have resolved to rely on test results to guide decision making.
Businesses will require a return-to-work pandemic strategy to keep their employees safe. They also have to meet regulatory and public health standards. For those that use the WHO’s testing – isolation – treatment strategy to mitigate the spread of SARS-CoV-2 virus will need to come up with a good testing strategy to ensure that employees that have contracted the COVID-19 do not go undetected.
More employees are testing positive in businesses due to the fact that long periods of work prolonged close contact among the workers putting each one of them at risk for exposure to SARS-CoV-2. According to research the interaction between workers and COVID-19 symptomatic, asymptomatic or pre-symptomatic individuals occur due to shared transportation and housing.
Therefore, there is a need to test and monitor workers at different points in time to ensure that the organization is coronavirus free. It can be a bit challenging and costly for high-density critical infrastructure workplaces. Testing is important to first identify employees with COVID-19, and exclude them from the workplace, hence preventing the transmission of the disease and any subsequent outbreaks in the firm.
For accurate results most business prefer to use a combination of molecular RT-PCR tests (swab test) and antibody tests (blood draw test). These two testing techniques complement each other and they prevent COVID-19 infected persons from testing negative. The main aim of screening for coronavirus in organizations is to protect the health of workers and that of the general public.
PCR tests for businesses are done to identify the current scope and magnitude of SARS-CoV-2 infection. On the other hand, antibody testing provides a history of previous infection and the type of immune response of the individual. The results from the two tests have shown to help a lot of organizations in decision making and the development of control measures to stem the spread of the COVID-19 virus.
For quick and effective action, businesses will require the use of rapid medical devices or kits. Nucleic acid or antigen testing methods are very accurate but take time before the results are out. The need for fast and accurate testing solution gave rise to rapid antibody tests which take less time. Screening an employee using a rapid COVID-19 antibody test kit will produce results within a timeframe of 10 minutes.
Therefore, businesses winging to open its doors will need a symptom-based and a test-based strategy to help mitigate the spread of COVID-19 infection among the employees in the workplace. For antibody testing, organizations will require the use of reliable coronavirus antibody test kits because diagnostic tests for COVID-19 antibodies need to be accurate and provide results as soon as possible.
There are many guidelines in place designed by agencies such as FDA and CDC in relation to employee testing and contact tracing that needs to be fulfilled to allow workers back to their workplaces. The great workplace testing dilemma among companies is mostly caused with the cost of testing and the uncertainty that come with it – usually based on the accuracy of the testing kits.
According to CDC and other advisory agencies, antibody testing should not be used solely to diagnose someone with an active SARS-CoV-2 infection. Business may prefer to combine molecular and antibody testing, where RT-PCR tests are taken at a single point in time and antibody tests are done at different points in time – serial testing.
More companies opt for affordable, available and easy-to-implement on-site testing solutions. Most of them rely on symptom screening, temperature checks, physical or social distancing, hand washing and sanitization and wearing effective face coverings. Some startups and large companies have invested in advanced technologies that track COVID-19 on surfaces and spread of the disease among the employees.
While these measures and technologies help, they are not enough to detect the virus. These interventions can still allow asymptomatic and pre-symptomatic individuals to transmit the virus. The best option would be the use of a coronavirus antibody testing kit to diagnose for COVID-19. The risk associated with antibody testing is related to the accuracy of the results, negative-false results lead to more spread of COVID-19.
Experts recommend for the development of safety protocols that include regular and mandatory testing. Privacy issues and availability of testing tools is making it hard for most companies to implement their return to work strategies. The need to bring employees back to work amid the spread of coronavirus is a costly venture; there are companies that have paid up to $20,000 a week to test about 100 employees.
A range of affordable mass screening point-of-care tests are available on order from different authorized distributors such as Rapid Connect Medical. This company allows companies and investors to make bulk test kit orders through its rapid-ship response team. If you would like to get more information on the testing capability of their covid-19 antibody test kits, feel free to contact Rapid Connect Medical and place your order today.
The sampling done with the rapid COVID-19 antibody test kit cassette using lateral flow from Rapid Connect Medical will give you the IgG and IgM detectable diagnostics results from between two and ten minutes. It can be used for reference in combination with the results from an RT-PCR (reverse transcriptase-polymerase chain reaction) test. A single finger prick to draw blood can be used with our kit that detects antibodies. This positive or negative result can be detected as soon as 3 days after exposure to COVID-19 (sometimes before the onset of symptoms occur). Knowing if you have active igM antibodies even in the first week of infection can help get the best treatment for an infected person.
If you do test positive, potentially exposed, or have traveled to a region with high infection rates, you should seek care from your doctor for treatment and continue to test for IgG antibodies daily until you are cleared to leave quarantine. The sensitivity, specificity, and accuracy or our antibody test kit is very high. This testing method for the public gives real time results and helps to identify initial infection before the severe flu like symptoms begin. This kit is intended to be administered by a health care professionals and providers.
The kits used for diagnostic tests for COVID-19 antibodies are usually designed for research use or qualitative detection of coronavirus, and not home use. Also, they can only be used to test the presence of IgG and IgM antibodies against SARS-CoV-2. Since they are aiding tools to RT-PCR or CT scanning, a clinical diagnosis of COVID-19 should be done by a healthcare professional or physician.
An antibody detection test cassette contains antigens from SARS-CoV-2 combined with gold nanoparticles. The device has two wells (one for specimen and one buffer) and a control region on the upper end. Two types of antibodies are of great importance in diagnostic tests for COVID-19 antibodies: Immunoglobulin M (IgM) and Immunoglobulin G (IgG).
The importance of the gold nanoparticles in the detection test cassette is to create a colored line in the control region. Antigens targeting a specific antibody are located in their respective regions on the nitrocellulose membrane of the test cassette. The IgG and IgM regions are coated with anti-human antibodies for each.
The rapid COVID-19 antibody test kits you will find on the market are designed to detect SARS-CoV-2-specific antibodies. The ones distributed by Rapid Connect Medical are FDA research approved and evaluated and validated by a comprehensive clinical study. This antigen test kit was developed in response to the COVID-19 global pandemic and offers a power tool for health care providers. The immune response produced by a Coronavirus viral infection is what this test measures. The CDC testing standards for laboratories were strictly followed during the clinical trials for our antibody test kit.
This is a serology elisa based test for SARS-CoV-2 antibodies in serum or plasma components of blood. Information on the collection data, total sample size, and validation of lab samples can be found here for review. Interpretations of test results should be confirmed with a lab and a a medical professional should diagnose your infection status not only on the sole basis of your rapid test kit results. This rapidtest should be performed by a licensed medical professional and your infection status determination may require additional tests.
Rapid Connect Medical distributes large orders of Coronavirus (SARS-CoV-2) IgM/IgG rapid test kits to global professional sports league and arenas. Rapid Connect Medical is the leading provider of Covid-19 Antibody test kits in small quantities, 25 test kit packs, as well as bulk orders for large countries, companies, and organizations. If your institute or corporation is in the need of antibody test kits, feel free to email our sales team. The company covers the USA, Canada, South America, and European territories. Therefore, if you are from these areas, Rapid Connect Medical will be able to assist you with availability, pricing, and ordering. Our test kit is considered to be the best product on the market for rapid Covid-19 antibody testing.
Our test kits are FDA EUA (Emergency Use Authorization) Authorized, have the CE Declaration for authorized European Union distribution, and have an authorization for use by the HHS for Pharmacies and Pharmacists. Federal guidance has been issues for Rapid Connect Medical’s COVID-19 Antibody test kit that is 98.23% accurate with results in 2 to 10 minutes. Don’t take a risk using inferior test kits, our Antibody Test kits are tested in a biotechnology laboratory!
The development of the technology for this screening standard with confirmed scientific accuracy is unique to Rapid Connect Medical‘s Antibody Test Kit. If you are interested in order a large quantity for commercial, biomedical, biological, science, or pharmaceutical applications and have questions, feel free to book a call with our sales team. In response to the global demand, our manufacturers have the capacity to support your required production needs. Covid-19 testing is also covered by many insurance plans.
Certification and Authorization – COVID-19 antibody test kits from Rapid Connect Medical are safe for use under the Emergency Use Authorization (EUA) of the FDA (Food and Drug Administration). They also are authorized by The U.S. Department of Health and Human Services (HHS) for Pharmacy or Pharmacist use. The antibody test kits come with a CE Declaration, meaning that they are clear for use in countries that fall under the European Union.
Storage and Quality – the Coronavirus antibody testing kits from Rapid Connect Medical have a shelf life of 24 months from the date of manufacture.
Ease of Use – the COVID-19 antibody test kits from Rapid Connect Medical are easy to use and you can get your results in two to ten minutes. The antibody test kits are designed for medical professional use and not as an over-the-counter product for home use.
Technology – the rapid serologic COVID-19 antibody test kits from Rapid Connect Medical use lateral flow technology.
We offer fast shipping methods for our antibody test kits at an affordable rate. You can order test kits online at https://rapidconnectmedical.com/